Finland· FI-REL-REL29263
Avandamet
A metformin and rosiglitazone product containing rosiglitazone + metformin hydrochloride, registered in Finland by Paranova Oy. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Metformin and rosiglitazone is registered in 4 of 19 countries.
Countries holding a registration under ATC A10BD03 (metformin and rosiglitazone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Metformin and rosiglitazone · ATC A10BD03
4 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Rosiglitazone + Metformin hydrochloride
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- A10BD03
- ATC class
- Metformin and rosiglitazone
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and rosiglitazone.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and rosiglitazone · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and rosiglitazone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db35c7be-7a68-41eb-bc73-d4fb8c2d1b02 GET /v1/drugs/db35c7be-7a68-41eb-bc73-d4fb8c2d1b02?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "ED",
"strength": "4 mg / 1000 mg",
"atc_label": "metformiini ja rosiglitatsoni",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/03/258/012",
"fimea_rel_id": "REL29263",
"authorised_at": "2007-08-09"
}See everything about metformin and rosiglitazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.